Navigation Links
Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/28/2009

HORSHAM, Pa., May 28 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that data related to several compounds will be presented at the 45th American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Fla., from May 29 to June 2, 2009. The studies were sponsored by Centocor Ortho Biotech Products, L.P. or its research partner, Ortho Biotech Oncology Research and Development, a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

"We are pleased that ASCO has accepted these data for presentation at their annual meeting," said Thomas Schaible, Vice President, Medical Affairs, Centocor Ortho Biotech. "Through our ongoing investigation of key clinical compounds, Centocor Ortho Biotech is committed to advancing the understanding of the therapeutic options it offers to patients fighting cancer."

Data from the following studies have been selected for presentation and posters:

  • Relationship of rapid M protein reduction to outcomes in a trial of pegylated liposomal doxorubicin (PLD) plus bortezomib (B) versus B alone in previously treated multiple myeloma (MM) (Abstract 8591) General Poster Session, Saturday May 30, 8:00 am to 12:00 pm, Level 2, West Hall C

Authors: J. J. Shah, A. Londhe, K. C. Lantz, C. Lowery, R. Z. Orlowski; University of Texas M. D. Anderson Cancer Center, Houston, TX; Centocor Ortho Biotech Services LLC, Horsham, PA

  • Correlation of CA-125 and RECIST evaluation in recurrent ovarian cancer (ROC): Results from a randomized phase III study of trabectedin (T) with pegylated liposomal doxorubicin (PLD) versus PLD alone (Abstract 5550)

General Poster Session, Sunday May 31, 2:00 pm to 6:00 pm, Level 2, West Hall C

Authors: T.
'/>"/>

SOURCE Centocor Ortho Biotech Products, L.P.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
2. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
3. Centocor/Janssen-Cilags Ustekinumab Will Become the Gold Standard for Psoriasis By 2011
4. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
6. GeneNews provides Centocor access to its osteoarthritis program
7. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
8. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
9. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
10. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
11. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...,, INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-Fir...yannouncedthatNASDAQhasestablishedNovember27,2009a...dtostockholdersresultingfromthesecuritizationtrans...aidonDecember15,2009toallstockholdersofrecordonthe...tepershareamountofthedividendat$1.67pershareofcomm...
(Date:11/23/2009)...,, BURNABY,BC,Nov.23/PRNewswire/-InimexPharm...haelJ.Abrams,Ph.DasitsPresidentandCEO. ,, Abram...texperiencetoInimex.Heisaco-inventorofthenuclearme...996atJohnsonMatthey,plcwherehewasManager,Biomedica...tofAnorMEDinLangley,BCandwasPresidentandCEOfrom199...
(Date:11/20/2009)..., Spain and Latin American countries have an oppo...y sectors. Researchers from the University of Vale...ation, have studied the productive fabric of the S... that Spain,s food and plant sectors have more clo...iotechnology as applied to food and plants has bee...
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-First... MTA: CTIC) announced today that the Ninth Circuit...rder and ruled that CTI should be allowed to pursu...g the case back to the District Court for trial. ...s former third-party reimbursement consultant for ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
...K, Calif., Feb. 24 Novasys Medical, Inc., a devel...nounced today that Noridian,Administrative Service...benefits in nine states, is now covering the non-s...inary incontinence (SUI). Noridian currently,admi...are beneficiaries in,Alaska, Arizona, Montana, Nor...
...OTTE, N.C., Feb. 24 The Charlotte-Mecklenburg reg... economic issues. In,Mecklenburg County, the NC F...nd for services in over 10 years. Sally Gilbert, ...llness event, the Charlotte Anti-Aging Expo &,... "We can all have a vibrant and healthy lifestyle....
... Feb. 24 Mindset BioPharmaceuticals (USA) Inc ("M...nd other shareholders announced today that it has ...o patent applications describing the use of insuli...t of memory loss. Drugs of this type include Rosig... for the treatment of type II diabetes mellitus. ...
Other Biology Technology:Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2Charlotte Anti-Aging Expo & Symposium Supports Free Clinics 2Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss 2Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss 3
(Date:11/23/2009)...The National Institute of General Medical Sciences...h (NIH), is investing $42.3 million for grants in ...ties (GO)." NIH developed the GO grant program to ...g funds provided by the American Recovery and Rein...nd projects that promise to have a significant imp...
(Date:11/23/2009)... A new study from Perth,s Telethon Institute for ...amount and timing of alcohol consumption in pregna... The study has just been published online in the i...Colleen O,Leary said the analysis was drawn from a...eted a questionnaire three months after the baby,s...
(Date:11/23/2009)...Carlos Mara Romeo Casabona is Director of the Inte...nome at Deusto University and the University of th...e up of jurists but also has other experts such as...edicine and even specialists in ethics. , The In...Genome at the Universities of Deusto and the Basqu...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3New study links alcohol in pregnancy to child behavior problems 2Research and legislation should go hand in hand, as much as possible 2Pharmasset to Present at Canaccord Adams Conference 13394 1Pharmasset to Present at Canaccord Adams Conference 13394 2Pharmasset to Present at Canaccord Adams Conference 13394 3Autism May Hinder Ability to Read Body Language 53773 1Autism May Hinder Ability to Read Body Language 53773 22009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition 53770 1
...People around the world will soon have access to a...ual exploration of the cardiovascular system creat...rt medical imaging and computer-generate animation...nder Tsiaras, Anatomical Travelogue, will allow us...etwork of arteries and veins and as it becomes inf...
...N ARBOR, Mich.---University of Michigan researcher...gerprints" in coal to track down sources of mercur...ublished in today,s online issue of the journal E...a naturally occurring element, but some 2000 tons ...enerated sources such as incinerators, chlorine-pr...
...oteins found in sperm are central to understanding...ew diagnostic methods and fertility treatments acc...lar and Cellular Proteomics (MCP). The article de...focusing on the function of proteins in a cell, ca...identify which proteins in sperm cells are dysfunc...
Other Biology News:TheVisualMD.com launches new animated 3-D views of human body in action 2'Fingerprinting' method tracks mercury emissions from coal 2'Fingerprinting' method tracks mercury emissions from coal 3Proteins in sperm unlock understanding of male infertility says new study 2
... Antigen Design , Customer Peptide Synthesis , 2...bove 90% , 20 mg will return to customer for fut... Rabbits x 2 , Maintenance 102 days/each , ... injections x5 /each , Test bleed (app. 5 ml) ...
...t Contains the following: , Coated Capture Antib..., Wash/Sample Diluent: 300 mL of 2X concentrate ,...yophilized peptide , Lyophilized Standard Diluen...ncentrate , Secondary Antibody-HRP: 30 microL of...
THP-1 Cell Slide from ProSci, Inc
Acrylamide/Bis 19:1 40% (w/v) solution from Ambion
Biology Products: